Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment.


Journal

Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963

Informations de publication

Date de publication:
May 2019
Historique:
received: 14 06 2018
accepted: 20 08 2018
pubmed: 10 9 2018
medline: 14 8 2019
entrez: 10 9 2018
Statut: ppublish

Résumé

Tau aggregation is a hallmark of a group of neurodegenerative diseases termed Tauopathies. Reduction of aggregation-prone Tau has emerged as a promising therapeutic approach. Here, we show that an anti-aggregant Tau fragment (F3

Identifiants

pubmed: 30196394
doi: 10.1007/s12035-018-1326-z
pii: 10.1007/s12035-018-1326-z
pmc: PMC6476873
doi:

Substances chimiques

Peptide Fragments 0
Protein Aggregates 0
tau Proteins 0

Types de publication

Journal Article

Langues

eng

Pagination

3751-3767

Références

Lancet. 2000 Jan 15;355(9199):192-7
pubmed: 10675119
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5129-34
pubmed: 10805776
J Biol Chem. 2000 Sep 29;275(39):30335-43
pubmed: 10869348
J Biol Chem. 2001 Dec 21;276(51):48165-74
pubmed: 11606569
Development. 2001 Nov;128(22):4475-88
pubmed: 11714673
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9980-5
pubmed: 12872001
J Biol Chem. 1992 Sep 25;267(27):19705-9
pubmed: 1527090
Methods Mol Biol. 2005;299:35-51
pubmed: 15980594
J Biol Chem. 2006 Jan 13;281(2):1205-14
pubmed: 16246844
Brain Pathol. 1991 Apr;1(3):213-6
pubmed: 1669710
J Neurosci. 2007 Mar 14;27(11):2896-907
pubmed: 17360912
Science. 2007 May 4;316(5825):750-4
pubmed: 17478722
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10252-7
pubmed: 17535890
J Neurosci. 2008 Jan 16;28(3):737-48
pubmed: 18199773
J Neurosci. 1991 Nov;11(11):3679-83
pubmed: 1941102
Biochem Biophys Res Commun. 2009 Oct 2;387(4):682-7
pubmed: 19622344
Hum Mol Genet. 2009 Nov 1;18(21):4153-70
pubmed: 19654187
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2557-62
pubmed: 21248227
Neurobiol Aging. 2011 Dec;32(12):2325.e7-16
pubmed: 21316815
J Neurosci. 2011 Feb 16;31(7):2511-25
pubmed: 21325519
Am J Pathol. 1990 Nov;137(5):1253-70
pubmed: 2146882
Mol Neurodegener. 2011 Jun 06;6:39
pubmed: 21645391
Nature. 2011 Jun 15;475(7354):96-100
pubmed: 21677644
Acta Neuropathol. 2012 Jun;123(6):787-805
pubmed: 22532069
Hum Mol Genet. 2012 Aug 15;21(16):3587-603
pubmed: 22611162
J Neurosci. 2012 Jun 13;32(24):8270-83
pubmed: 22699908
J Am Chem Soc. 2013 Feb 20;135(7):2853-62
pubmed: 23360400
J Med Chem. 2013 Jun 13;56(11):4135-55
pubmed: 23484434
J Neurosci. 2013 Jul 31;33(31):12887-97
pubmed: 23904623
J Phys Chem B. 2014 Mar 27;118(12):3326-34
pubmed: 24601594
Chem Biol. 2014 Sep 18;21(9):1102-14
pubmed: 25237857
Acta Neuropathol Commun. 2014 Oct 21;2:146
pubmed: 25330988
J Biol Chem. 2014 Dec 5;289(49):34389-407
pubmed: 25339173
AAPS J. 2015 Jan;17(1):134-43
pubmed: 25366889
Behav Pharmacol. 2015 Jun;26(4):353-68
pubmed: 25769090
Proc Natl Acad Sci U S A. 2015 Jun 16;112(24):7501-6
pubmed: 26034266
Nature. 2015 Oct 15;526(7573):351-60
pubmed: 26469046
Curr Alzheimer Res. 2015;12(9):814-28
pubmed: 26510979
Nat Rev Neurosci. 2016 Jan;17(1):5-21
pubmed: 26631930
J Neurosci. 2016 Jan 20;36(3):1001-7
pubmed: 26791227
Lancet. 2016 Dec 10;388(10062):2873-2884
pubmed: 27863809
PLoS One. 2016 Dec 22;11(12):e0167432
pubmed: 28006031
Alzheimers Dement. 2017 Nov;13(11):1270-1291
pubmed: 28528849
Neurobiol Aging. 2017 Sep;57:47-63
pubmed: 28600952
PLoS Biol. 2017 Jul 6;15(7):e2002183
pubmed: 28683104
Annu Rev Neurosci. 2017 Jul 25;40:189-210
pubmed: 28772101
Nat Neurosci. 2018 Jan;21(1):72-80
pubmed: 29273772
EMBO J. 2018 Apr 3;37(7):
pubmed: 29472250
Genetics. 1974 May;77(1):71-94
pubmed: 4366476
J Neurochem. 1994 Oct;63(4):1416-25
pubmed: 7931292
J Biol Chem. 1994 Apr 22;269(16):11776-82
pubmed: 8163474
Neuron. 1993 Jul;11(1):153-63
pubmed: 8393323
Nature. 1996 Oct 10;383(6600):550-3
pubmed: 8849730
FEBS Lett. 1996 Dec 16;399(3):344-9
pubmed: 8985176

Auteurs

Ghulam Jeelani Pir (GJ)

German Center for Neurodegenerative Diseases (DZNE), Sigmund-Freud-Str. 27, 53127, Bonn, Germany. Jeelani.Pir@dzne.de.
Max-Planck-Institute for Metabolism Research, Hamburg Outstation, c/o DESY, Notkestrasse 85, 22607, Hamburg, Germany. Jeelani.Pir@dzne.de.

Bikash Choudhary (B)

German Center for Neurodegenerative Diseases (DZNE), Sigmund-Freud-Str. 27, 53127, Bonn, Germany.
Max-Planck-Institute for Metabolism Research, Hamburg Outstation, c/o DESY, Notkestrasse 85, 22607, Hamburg, Germany.

Senthilvelrajan Kaniyappan (S)

German Center for Neurodegenerative Diseases (DZNE), Sigmund-Freud-Str. 27, 53127, Bonn, Germany.
Max-Planck-Institute for Metabolism Research, Hamburg Outstation, c/o DESY, Notkestrasse 85, 22607, Hamburg, Germany.

Ram Reddy Chandupatla (RR)

German Center for Neurodegenerative Diseases (DZNE), Sigmund-Freud-Str. 27, 53127, Bonn, Germany.
Max-Planck-Institute for Metabolism Research, Hamburg Outstation, c/o DESY, Notkestrasse 85, 22607, Hamburg, Germany.

Eckhard Mandelkow (E)

German Center for Neurodegenerative Diseases (DZNE), Sigmund-Freud-Str. 27, 53127, Bonn, Germany.
Max-Planck-Institute for Metabolism Research, Hamburg Outstation, c/o DESY, Notkestrasse 85, 22607, Hamburg, Germany.
CAESAR Research Center, Ludwig-Erhard-Allee 2, 53175, Bonn, Germany.

Eva-Maria Mandelkow (EM)

German Center for Neurodegenerative Diseases (DZNE), Sigmund-Freud-Str. 27, 53127, Bonn, Germany. Eva.Mandelkow@dzne.de.
Max-Planck-Institute for Metabolism Research, Hamburg Outstation, c/o DESY, Notkestrasse 85, 22607, Hamburg, Germany. Eva.Mandelkow@dzne.de.
CAESAR Research Center, Ludwig-Erhard-Allee 2, 53175, Bonn, Germany. Eva.Mandelkow@dzne.de.

Yipeng Wang (Y)

German Center for Neurodegenerative Diseases (DZNE), Sigmund-Freud-Str. 27, 53127, Bonn, Germany. yipeng810@qq.com.
Max-Planck-Institute for Metabolism Research, Hamburg Outstation, c/o DESY, Notkestrasse 85, 22607, Hamburg, Germany. yipeng810@qq.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH